A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients

This was a phase I/II study testing the feasibility of a vaccine by autologous leukemic apoptotic corpse-pulsed dendritic cells (DC) in elderly acute myeloid leukemia (AML) patients in first or second complete remission. Pulsed DC were administered at doses of 9 × 106 subcutaneously (1 mL) and 1 × 1...

Full description

Bibliographic Details
Main Authors: Patrice Chevallier, Soraya Saiagh, Virginie Dehame, Thierry Guillaume, Pierre Peterlin, Sylvain Bercegeay, Yannick Le Bris, Céline Bossard, Isabelle Gauvrit, Brigitte Dreno, Nadine Juge-Morineau, Marie C. Béné, Marc Gregoire
Format: Article
Language:English
Published: Taylor & Francis Group 2021-10-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
dendritic cells
vaccine
aml
apoptotic corpses
Online Access:http://dx.doi.org/10.1080/21645515.2021.1943991

Internet

http://dx.doi.org/10.1080/21645515.2021.1943991

Similar Items